The Antivirals Outlook to 2007: Marketing opportunities by disease state, patient potential and product profile

Executive Summary

The global antivirals market is forecast to grow from $8.7bn in 2001 to $14bn in 2007, largely due to the high incidence of viral infections and the inadequate efficacy of the drugs currently available. The patient pool is also increasing with pharmaceutical companies targeting developing countries, thus creating a phenomenal opportunity for new drugs and therapies in the antivirals market. The new management report "The Antivirals Outlook to 2007: Marketing opportunities by disease state, patient potential and product profile’, is a single source guide to all key epidemiological, market and pipeline information. The report also details the epidemiology by disease segment and forecasts the patient pool, market size and drivers of growth for the various antiviral segments up to 2007. The changing dynamics of the antiviral market require pharmaceutical executives to stay abreast of the current and future market developments to be competitive. This report is simply the "must-have" decision-making tool for across pharma and biotech companies.